This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
DETROIT, July 9, 2013 (GLOBE NEWSWIRE) --
Covisint, a Compuware (Nasdaq:CPWR) company, today announced that it has published a
toolkit offering a comprehensive set of resources that outline the benefits of and uses for
Direct messaging for key
healthcare stakeholders. Collectively, these items answer common questions, dispel misconceptions and outline how Direct messaging makes
healthcare providers eligible for federal monies and Meaningful Use Stage II requirements.
whitepaper addressing whether Direct replaces HIEs, while also examining redundancies and HIPAA requirements ( The Direct Evolution; Why It Will Change How You Communicate);
guidebook on workflow integration and internal champions ( Steps to Direct Success); and,
research on why to adopt Direct ( Why You Need to Invest Today).
Direct messaging has received a large boost recently in two ways since it:
is federally driven -- the Office of the National Coordinator (ONC) and the Centers for Medicare and Medicaid (CMS) are increasingly requiring Direct to be part of the ecosystems of state Medicaid agencies and
health information exchange (HIE) projects; and,
advances Meaningful Use Stage II qualification -- in order to continue receiving Meaningful Use funds and incentives, individual providers and hospitals are required to use a Direct solution.
"The momentum behind Direct is nearing the tipping point," said John Stanley, Principal, Impact Advisors. "Most healthcare providers and facilities are aware of Direct and are preparing a deployment plan."